Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus With CNI or Steroid Withdrawal in Kidney Transplant
NCT00371826Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2006
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of everolimus in kidney transplantation (3 arms), sponsored by Novartis. Primary endpoint: Calculated Glomerular Filtration Rate at 12 months. Started Mar 2006; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00371826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371826.